Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...
The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor ...
A UC San Diego study reveals GLP-1 receptor agonists, like Ozempic, may significantly reduce colon cancer death rates.
MedPage Today on MSN
GLP-1s Tied to Big Survival Advantage in Colon Cancer Patients
In a retrospective analysis, patients with colon cancer taking GLP-1 agonists had a 62% lower risk of 5-year mortality ...
The FDA has approved a groundbreaking blood test for colon cancer screening, offering a less invasive and more accessible ...
The city of Wahoo has lifted its boil water advisory. Residents in Wahoo and Colon no longer need to boil their water or use ...
While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new ...
FOX 35 Orlando on MSN
Former Lake Mary teacher pleaded guilty to inappropriate relationship with minor, prosecutors say
A former Seminole County teacher pleaded guilty to four charges stemming from a misconduct investigation last year, involving ...
One twin got colon cancer at 21. The other didn't. Their story illustrates the mysterious nature of the rise of colon cancer ...
HMRC has clarified a restriction that applies when completing the self-assessment form. There are various reasons why you may ...
Research institutions around the world house valuable genetic information that could help unlock countless medical mysteries.
Everyday Health on MSN
GLP-1 Drugs Like Ozempic May Boost Colon Cancer Survival
People with colon cancer who took GLP-1 drugs were less likely to die within 5 years than people not on GLP-1s, a new study finds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results